Vaxxinity, Inc. Class A Common Stock
VAXX
VAXX was delisted on the 8th of May, 2024.
12 hedge funds and large institutions have $76.6M invested in Vaxxinity, Inc. Class A Common Stock in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 6 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
25% less capital invested
Capital invested by funds: $102M → $76.6M (-$24.9M)
29% less funds holding
Funds holding: 17 → 12 (-5)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$86.5K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$59.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$685K |
| 2 |
Millennium Management
New York
|
-$489K |
| 3 |
HF
HRT Financial
New York
|
-$187K |
| 4 |
DFCM
Dark Forest Capital Management
San Juan,
Puerto Rico
|
-$101K |
| 5 |
CCM
CAAS Capital Management
New York
|
-$94K |
VAXX Hedge Fund Activity: Q1 2022 in Review
12 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Vaxxinity, Inc. Class A Common Stock (VAXX) for Q1 2022, worth a combined $76.6M — down 25% from $102M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of VAXX and 1 opened new positions — a net loss of 5 holders — while 6 trimmed existing stakes and 1 added.
The largest buyer was Bank of America, adding an estimated $86.5K. The largest seller was Goldman Sachs, cutting an estimated $685K.
- 12 institutional investors held Vaxxinity, Inc. Class A Common Stock (VAXX) as of Q1 2022, down from 17 in Q4 2021.
- Funds reported $76.6M of Vaxxinity, Inc. Class A Common Stock stock for Q1 2022, down 25% quarter-over-quarter.
- 1 fund opened new Vaxxinity, Inc. Class A Common Stock positions in Q1 2022 and 6 closed out, a net change of -5 holders.
- The largest Vaxxinity, Inc. Class A Common Stock buyer in Q1 2022 was Bank of America, an estimated $86.5K added.
- The largest Vaxxinity, Inc. Class A Common Stock seller in Q1 2022 was Goldman Sachs, an estimated $685K sold.
Based on aggregated 13F filings for Q1 2022.